Idenix Pharmaceuticals (IDIX) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the U.S. and Europe. This stock is trading up 4% at $8.69 in recent trading.
Today's Range: $8.36-$8.7852-Week Range: $4.03-$15.25 Volume: 773,000 Three-Month Average Volume: 1.6 million >>5 Stocks That Could Crush the Bears From a technical perspective, IDIX is spiking notably higher here as the stock moves within range of a near-term breakout trade. That trade will hit once IDIX takes out some near-term overhead resistance at $9.25 to $9.30 with volume. Traders should look for long-biased trades if IDIX can sustain a move or close above those levels with volume that's near or above 1,609,720 shares. If we get that action soon, then IDIX can easily trend back towards its next significant overhead resistance levels at $10.42 to $11.92. Keep in mind that in order for IDIX to hit those targets, then this stock has to maintain a trend above its 50-day at $9.30 with strong upside volume flows.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts